Forest Laboratories Inc. (NYSE: FRX ) has announced the positive news about the phase III of its study of aclidinium bromide in Chronic Obstructive Pulmonary Disease. Read More
Shares of InfoSpace Inc. surged after the company lifted its fourth-quarter revenue and profit forecasts. _ Read More